SEARCH
Covaxin 77.8% effective against Covid-19 in Lancet study
NYOOOZ TV
2021-11-12
Views
4
Description
Share / Embed
Download This Video
Report
Analysis data on the safety and efficacy of Bharat Biotech’s vaccine against Covid-19, Covaxin, following its Phase 3 clinical trials, has been peer-reviewed and published in the medical journal, The Lancet.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x85gisb" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:33
Covaxin 77.8% effective against Covid: Lancet
03:16
Covaxin is 77.8 percent effective against Covid-19 virus says study | Oneindia News
02:03
Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News
08:19
'Covaxin 50% Effective Against Delta Variant' The Lancet Publishes Study NewsX
02:13
Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News
00:53
Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19 _ TV9News
02:34
Covaxin provides only 50 percent protection against Covid-19, says The Lancet | Oneindia News
01:54
Covaxin More Effective Against Second Variant Of Covid-19
09:49
Covaxin Effective Against Double Mutant Strain Of Covid-19 Found In India, ICMR Study
00:30
Bharat Biotech: Covaxin booster dose effective against neutralising Omicron and Delta variants of COVID-19
00:58
Covaxin doses 50% effective against COVID-19
01:33
COVAXIN overall 77.8% effective in Phase-3 trial : Bharat Biotech
